Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

3 Reasons to Buy Medtronic Stock
3 Reasons to Buy Medtronic Stock

Over the past few years, medical device companies have struggled as the pandemic disrupted much of the industry, and economic problems contributed to lower sales and increasing expenses. Healthcare

If You Invested $25,000 in UnitedHealth Stock 10 Years Ago, This Is How Much You Would Have Today
If You Invested $25,000 in UnitedHealth Stock 10 Years Ago, This Is How Much You Would Have Today

UnitedHealth Group (NYSE: UNH) has been a top healthcare stock to own for years. Today, it's among the largest healthcare companies in the world, worth $475 billion. Although it's a health insurer

If You Invested $25,000 in UnitedHealth Stock 10 Years Ago, This Is How Much You Would Have Today
If You Invested $25,000 in UnitedHealth Stock 10 Years Ago, This Is How Much You Would Have Today

UnitedHealth Group (NYSE: UNH) has been a top healthcare stock to own for years. Today, it's among the largest healthcare companies in the world, worth $475 billion. Although it's a health insurer

Down 15% in 2023, Should You Buy the Dip With Illumina Stock?
Down 15% in 2023, Should You Buy the Dip With Illumina Stock?

Illumina's (NASDAQ: ILMN) stock is down by 15% this year so far, and it's no surprise why. With the new disclosure of a Securities and Exchange Commission (SEC) investigation into its bedraggled

Down 15% in 2023, Should You Buy the Dip With Illumina Stock?
Down 15% in 2023, Should You Buy the Dip With Illumina Stock?

Illumina's (NASDAQ: ILMN) stock is down by 15% this year so far, and it's no surprise why. With the new disclosure of a Securities and Exchange Commission (SEC) investigation into its bedraggled

Down 15% in 2023, Should You Buy the Dip With Illumina Stock?
Down 15% in 2023, Should You Buy the Dip With Illumina Stock?

Illumina's (NASDAQ: ILMN) stock is down by 15% this year so far, and it's no surprise why. With the new disclosure of a Securities and Exchange Commission (SEC) investigation into its bedraggled

Should You Buy This Blue Chip Dividend Stock?
Should You Buy This Blue Chip Dividend Stock?

Because investing is future-oriented, it is important that investors purchase businesses with ample growth potential in the years ahead. The best way to do this is to only consider investing in

Why Shares of SomaLogic Are Up Tuesday
Why Shares of SomaLogic Are Up Tuesday

Shares of SomaLogic (NASDAQ: SLGC) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock

Why Shares of SomaLogic Are Up Tuesday
Why Shares of SomaLogic Are Up Tuesday

Shares of SomaLogic (NASDAQ: SLGC) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock

Why Shares of SomaLogic Are Up Tuesday
Why Shares of SomaLogic Are Up Tuesday

Shares of SomaLogic (NASDAQ: SLGC) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock

Should Value Investors Buy This Healthcare Stock?
Should Value Investors Buy This Healthcare Stock?

Value investing is a rather popular investing strategy. Seeing as almost everyone enjoys buying great products at discounted prices, it isn't surprising that we would also like to get good deals on

Will UnitedHealth Group Be a Trillion-Dollar Stock by 2030?
Will UnitedHealth Group Be a Trillion-Dollar Stock by 2030?

In the realm of investing, market capitalization is a good but not perfect way to gauge the success of a business. Sure, sometimes companies are overvalued. But a company's market value can at least

Will UnitedHealth Group Be a Trillion-Dollar Stock by 2030?
Will UnitedHealth Group Be a Trillion-Dollar Stock by 2030?

In the realm of investing, market capitalization is a good but not perfect way to gauge the success of a business. Sure, sometimes companies are overvalued. But a company's market value can at least

Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move
Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move

One of the great things about investing in stocks is that there is no need to have millions in the bank to get started. A relatively modest sum such as $1,000 can go a long way if invested shrewdly

Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move
Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move

One of the great things about investing in stocks is that there is no need to have millions in the bank to get started. A relatively modest sum such as $1,000 can go a long way if invested shrewdly

STAAR Surgical Teams Up With Tennessee Titans Quarterback Will Levis On Life Changing Vision Correction Procedure, EVO ICL
STAAR Surgical Teams Up With Tennessee Titans Quarterback Will Levis On Life Changing Vision Correction Procedure, EVO ICL


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced its partnership with Will Levis, quarterback for the

Is This MedTech Giant a Buy for Dividend Investors?
Is This MedTech Giant a Buy for Dividend Investors?

Buying industry-leading companies in industries with growth potential tends to produce delightful results for dividend investors. This is because such businesses can generate revenue and earnings

EQS-News: STRATEC POSTS FINAL RESULTS FOR FIRST HALF OF 2023
EQS-News: STRATEC POSTS FINAL RESULTS FOR FIRST HALF OF 2023
EQS-News: STRATEC POSTS FINAL RESULTS FOR FIRST HALF OF 2023
Why Natera Stock Is Soaring Today
Why Natera Stock Is Soaring Today

Shares of Natera (NASDAQ: NTRA) were soaring 18.7% higher at 11:04 a.m. ET on Friday. The big gain came after the DNA testing company announced its second-quarter results following the market close

EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
Cigna Group (CI) Q2 2023 Earnings Call Transcript
Cigna Group (CI) Q2 2023 Earnings Call Transcript

Image source: The Motley Fool.

Cigna Group (NYSE: CI)Q2 2023 Earnings CallAug 03, 2023, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Humana Foundation Announces 2023 Scholarship Awards
Humana Foundation Announces 2023 Scholarship Awards


The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced 81 winners of college scholarships awarded through the Humana Foundation Scholarship

This Deep Value Stock Is a Strong Buy
This Deep Value Stock Is a Strong Buy

Value investing can be a powerful strategy. Buying businesses for less than they are worth can limit your risk of significant capital losses, and it can increase your chances of future upside.

The

The Top Healthcare Stocks to Buy With $100
The Top Healthcare Stocks to Buy With $100

A high price tag sometimes indicates value, be it in equity markets or elsewhere. Still, excellent stocks can be had for a relatively modest sum. With just $100 or even less, investors can get their